Not finding it? Sign in to also search OpenAlex live.
-
Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study2025 EClinicalMedicine article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Vasileios Fragoulakis, Jesse Joachim Swen, Margarita-Ioanna Koufaki, Kathrin Blagec, Tanja Blagus, Stefan Böhringer, +35 more
9citations -
Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis: cost-utility analysis of the TARA trial2020 Annals of the Rheumatic Diseases article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access
Elise van Mulligen, Angelique E. A. M. Weel, Tjallingius Martijn Kuijper, N. H. A. M. Denissen, Andreas H. Gerards, Mike H de Jager, +5 more
21citations -
The Box—eHealth in the Outpatient Clinic Follow-up of Patients With Acute Myocardial Infarction: Cost-Utility Analysis2022 Journal of Medical Internet Research article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access
Roderick Willem Treskes, M. Elske van den Akker‐van Marle, Louise van Winden, Nicole van Keulen, Enno Tjeerd van der Velde, Saskia L.M.A. Beeres, +2 more
11citations -
The Box—eHealth in the Outpatient Clinic Follow-up of Patients With Acute Myocardial Infarction: Cost-Utility Analysis (Preprint)2021 preprint Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access
Roderick Willem Treskes, M. Elske van den Akker‐van Marle, Louise van Winden, Nicole van Keulen, Enno Tjeerd van der Velde, Saskia L.M.A. Beeres, +2 more
0citations -
Correction to: Nonoperative versus operative management of frail institutionalized older patients with a proximal femoral fracture: a cost-utility analysis alongside a multicenter prospective cohort study
Sverre A. I. Loggers, Alexandra J. L. M. Geraerds, Pieter Joosse, Hanna C. Willems, Taco Gosens, Romke van Balen, +7 more
3citations -
Correction to: Nonoperative versus operative management of frail institutionalized older patients with a proximal femoral fracture: a cost-utility analysis alongside a multicenter prospective cohort study
Sverre A. I. Loggers, Alexandra J. L. M. Geraerds, Pieter Joosse, Hanna C. Willems, Taco Gosens, Romke van Balen, +7 more
0citations -
Correction to: Nonoperative versus operative management of frail institutionalized older patients with a proximal femoral fracture: a cost-utility analysis alongside a multicenter prospective cohort study
Sverre A. I. Loggers, Alexandra J. L. M. Geraerds, Pieter Joosse, Hanna C. Willems, Taco Gosens, Romke van Balen, +7 more
0citations -
Nonoperative versus operative management of frail institutionalized older patients with a proximal femoral fracture: a cost-utility analysis alongside a multicenter prospective cohort study
Sverre A. I. Loggers, Alexandra J. L. M. Geraerds, Pieter Joosse, Hanna C. Willems, Taco Gosens, Romke van Balen, +7 more
19citations -
EE314 A Cost-Utility Analysis in Patients With Inflammatory Bowel Disease and Iron Deficiency Anemia in the Netherlands: Reduced Hypophosphatemia and Fracture Incidence With Ferric Derisomaltose Versus Ferric Carboxymaltose1citations
-
OP0130-HPR COST-UTILITY ANALYSIS OF LONGSTANDING EXERCISE THERAPY VERSUS USUAL CARE IN PEOPLE WITH RHEUMATOID ARTHRITIS AND SEVERE FUNCTIONAL LIMITATIONS2024 Annals of the Rheumatic Diseases article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life
M. Teuwen, Salima F. E. van Weely, Cornelia H. M. van den Ende, MAT van Wissen, T. P. M. Vliet Vlieland, W. F. Peter, +4 more
0citations -
Imaging-guided treatment strategy compared to standard care in at-risk individuals for rheumatoid arthritis: a cost-utility analysis2026 BMJ Open article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access
Sterre S. Bour, Elise van Mulligen, Lucas M. A. Goossens, Pascal H P de Jong, Annette H M van der Helm–van Mil, Maureen Rutten‐van Mölken
0citations -
POS0582 RISK-STRATIFIED COST-UTILITY ANALYSIS OF THE TREAT EARLIER TRIAL: ONE-YEAR METHOTREXATE TREATMENT FOR CLINICALLY SUSPECT ARTHRALGIA IS COST-EFFECTIVE IN ACPA NEGATIVE BUT NOT IN ACPA POSITIVE PATIENTS WITH AN INCREASED RISK FOR RA2025 Annals of the Rheumatic Diseases conference-abstract Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access
Elise van Mulligen, Quirine A Dumoulin, Maureen Rutten‐van Mölken, Annette H M van der Helm–van Mil
0citations -
Cost-utility analysis of a cluster randomized controlled trial implementing a structured osteoarthritis model in primary healthcare2021 Osteoarthritis and Cartilage article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access
Nina Østerås, Eline Aas, Tuva Moseng, Leti van Bodegom‐Vos, Krysia Dziedzic, Bård Natvig, +3 more
2citations -
COST-UTILITY ANALYSIS OF A MOLECULAR-INTEGRATED-PROFILE FOR WOMEN WITH (HIGH)INTERMEDIATE RISK ENDOMETRIAL CANCER - PORTEC-4A AN INTERNATIONAL, MULTICENTRE, RANDOMISED, PHASE 3 TRIAL2025 International Journal of Gynecological Cancer article Medicine Endometrial and Cervical Cancer Treatments
Anne Sophie V M van den Heerik, Nanda Horeweg, Marie A.D. Haverkort, Nienke Kuijsters, Stefan Kommoss, Friederike L.A. Koppe, +25 more
0citations -
Cost‐utility and cost‐effectiveness analysis of a clinical medication review focused on personal goals in older persons with polypharmacy compared to usual care: Economic evaluation of the DREAMeR study2020 British Journal of Clinical Pharmacology article Medicine Pharmaceutical Practices and Patient Outcomes Open access
Sanne Verdoorn, Jeroen van de Pol, Anke M. Hövels, Henk‐Frans Kwint, Jeanet W. Blom, Jacobijn Gussekloo, +1 more
26citations -
Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson’s Disease2022 Journal of Parkinson s Disease article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access
Constant V.M. Verschuur, Sven R. Suwijn, Rob J. de Haan, Judith A. Boel, Bart Post, Bas R. Bloem, +6 more
3citations -
Cost-effectiveness and cost-utility of an Acceptance and Commitment Therapy intervention vs. a Cognitive Behavioral Therapy intervention for older adults with anxiety symptoms: A randomized controlled trial2022 PLoS ONE article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access
Maartje Witlox, Vivian Kraaij, Nadia Garnefski, Ernst Thomas Bohlmeijer, Filip Smit, Philip Spinhoven
31citations -
POS0009 COST-UTILITY ANALYSIS OF THE TREAT EARLIER TRIAL: A ONE YEAR COURSE OF METHOTREXATE IN CLINICALLY SUSPECT ARTHRALGIA PATIENTS IS COST-EFFECTIVE2024 Annals of the Rheumatic Diseases conference-abstract Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life
Elise van Mulligen, Sterre S. Bour, Pascal H P de Jong, Maureen Rutten‐van Mölken, Annette H M van der Helm–van Mil
2citations -
FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial2022 European Journal of Nuclear Medicine and Molecular Imaging article Medicine Thyroid Cancer Diagnosis and Treatment Open access
Elizabeth J. de Koster, Dennis Vriens, Maarten O. van Aken, Lioe-Ting Dijkhorst-Oei, Wim J.G. Oyen, Robin Patrick Peeters, +3 more
23citations -
OP0007-HPR EFFECTIVENESS AND COST-UTILITY OF A MULTIMODAL, PHYSIOTHERAPIST-LED, VOCATIONAL INTERVENTION FOR PEOPLE WITH RHEUMATOID ARTHRITIS OR AXIAL SPONDYLOARTHRITIS AND A REDUCED WORK ABILITY: A RANDOMIZED, CONTROLLED TRIAL2025 Annals of the Rheumatic Diseases article Health Professions Medical Practices and Rehabilitation Open access
N. Bakker, Jesper Knoop, Wilbert B. van den Hout, Nathan Hutting, Josephine A. Engels, J. Bart Staal, +7 more
1citations -
Cost-utility of long-term exercise therapy in people with axial spondyloarthritis and severe functional limitations: a randomized, controlled trial2026 Rheumatology International article Medicine Spondyloarthritis Studies and Treatments Open access
MAT van Wissen, Salima F. E. van Weely, Cornelia H. M. van den Ende, T. P. M. Vliet Vlieland, M. Teuwen, Wilfred F. Peter, +7 more
0citations -
Cost-utility-analysis of molecular-integrated-profile for women with (high)intermediate risk endometrial cancer − PORTEC-4a an international, randomised, phase 3 trial2026 Radiotherapy and Oncology article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access
Anne Sophie V M van den Heerik, Nanda Horeweg, Marie A.D. Haverkort, Nienke Kuijsters, Stefan Kommoss, Friederike L.A. Koppe, +24 more
3citations -
An economic evaluation of the NightWatch for children with refractory epilepsy: Insight into the cost-effectiveness and cost-utility2022 Seizure article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access
Anouk Engelgeer, Anouk van Westrhenen, Roland D. Thijs, Silvia Evers
13citations -
Response to the letter to the editor by Pontoriero et al. regarding the article “Cost-utility-analysis of molecular-integrated-profile for women with (high)intermediate risk endometrial cancer – PORTEC-4a an international randomised phase 3 trial by Van den Heerik et al.”
Anne Sophie V M van den Heerik, Nanda Horeweg, Carien L. Creutzberg, Wilbert B. van den Hout
0citations